ResMed Inc
Sentinellis Health Score
10/10
$30.1B
$5.1B
20.0x
AI Summary
ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).
ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].
ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.
Recent News
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access
Simply Wall St· 2026-05-20Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Yahoo Finance· 2026-05-19Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Yahoo Finance· 2026-05-19
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full ResMed Inc analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Healthcare) or comparable health.